0001628280-24-011485.txt : 20240315
0001628280-24-011485.hdr.sgml : 20240315
20240315163047
ACCESSION NUMBER: 0001628280-24-011485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koenig Sheldon L.
CENTRAL INDEX KEY: 0001766524
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 24755288
MAIL ADDRESS:
STREET 1: C/O PORTOLA PHARMACEUTICALS, INC.
STREET 2: 270 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Esperion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001434868
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: 734-887-3903
MAIL ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: HDL THERAPEUTICS INC
DATE OF NAME CHANGE: 20080513
4
1
wk-form4_1710534636.xml
FORM 4
X0508
4
2024-03-14
0
0001434868
Esperion Therapeutics, Inc.
ESPR
0001766524
Koenig Sheldon L.
C/O ESPERION THERAPEUTICS, INC.
3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR
MI
48108
1
1
0
0
President and CEO
0
Common Stock
2024-03-14
4
A
0
454000
0
A
766816
D
Stock Option (right to buy)
2.05
2024-03-14
4
A
0
642000
0
A
2034-03-14
Common Stock
642000
642000
D
Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024.
/s/ Sheldon L. Koenig
2024-03-15